FTC looks to revive insulin lawsuit against pharma middlemen

Chairman of the Federal Trade Commission Andrew Ferguson says he plans to resume a lawsuit alleging that the three leading pharmacy benefit managers in the U.S. ran an illegal scheme that led to higher insulin prices.

His comments came a